In sharp contrast to earlier studies, patients with severe triple-vessel heart disease fared equally well whether they underwent open-heart bypass surgery (CABG) or a less invasive procedure called ...

Please provide your email address to receive an email when new articles are posted on . Like other specialties in medicine, cardiology has seen an influx in interest in less invasive therapeutic ...

In patients with acute coronary syndrome (ACS), coronary artery bypass graft (CABG) surgery performed 2-3 days after ticagrelor cessation showed noninferiority with respect to perioperative bleeding ...

Women continue to have a higher risk of mortality and morbidity after coronary artery bypass grafting (CABG) compared with men, with no significant improvements seen over the last decade, a ...

Coronary artery disease (CAD) is a major global health concern and one of the leading causes of death worldwide, caused primarily by the buildup of fatty plaque in the arteries that supply oxygen-rich ...

Sasha Still, M.D., an assistant professor of the UAB Division of Cardiothoracic Surgery, was recently featured on UAB's MedCast Podcast. During the episode, Still discusses the unique procedure of ...

Elderly patients with complex geriatric conditions and left main or multivessel coronary artery disease who experience an acute coronary syndrome—particularly NSTEMI or unstable angina—fare ...

Bypass surgery is a type of open-heart surgery. Surgeons may use several different types of bypass surgeries to repair or replace the heart. Open-heart surgery is an operation where surgeons repair or ...

MADRID — New data from two randomized trials suggest that dual antiplatelet therapy (DAPT) should be significantly shortened or not used at all after coronary artery bypass surgery (CABG). Researchers ...

When a modified surgical technique was used to gently remove sections of leg veins used in coronary artery bypass surgery, the grafts were less likely to become blocked and fewer people had a ...

Among patients who are already taking statins, giving additional doses in the hours before CABG isn’t worthwhile, the StaRT-CABG trial shows. The 30-day rate of MACCE (a composite of all-cause ...